Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com

Mobile Text Messages Improve Diabetes, Heart Risk Control

By Pearl Steinzor

September 2nd 2025

Weekly mobile messages improved blood sugar, blood pressure, and heart health risk management in patients with type 2 diabetes (T2D), a study finds.

Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes

By Pearl Steinzor

August 27th 2025

Woman with vision problem | Image credit: Jo Panuwat D - stock.adobe.com

Gaps Exist in Diabetic Retinopathy Screening Knowledge Among Providers, Study Finds

By Pearl Steinzor

August 26th 2025

METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes

By Pearl Steinzor

August 22nd 2025

eye health in a clinical setting-Microgen-stock.adobe.com

Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk

By Pearl Steinzor

August 18th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

Watch Now

Continuing Medical Education

View All

September 5th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 5th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

September 30th 2018

AADE Poster Presentations: A Look at Research Presented at the AADE Annual Conference

Mary Caffrey

POSTERS AT THE 2018 American Association of Diabetes Educators (AADE) Annual Conference covered updates on new therapies and technology, strategies to help patients overcome fear of using insulin, and innovations in diabetes self-management education and support. Following are a few snapshots of the research presented at AADE.

September 29th 2018

From the Editor-in-Chief: Technology Is a Great Tool, but the Team Makes the Difference

Robert Gabbay, MD, PhD, FACP

A letter from our Editor-in-Chief, Robert Gabbay, MD, PhD, FACP.

September 29th 2018

Podcast: This Week in Managed Care—Responding to CMS and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

September 28th 2018

From High Tech to Low, Livongo Meets People With Diabetes at Decision Points

Mary Caffrey

Livongo’s technology is built around the idea that a person living with diabetes must make multiple decisions every day, and the cumulative effect of all those decisions drives outcomes.

September 28th 2018

Through "Information Shift" and Support, North Carolina Program Brings Dramatic A1C, Therapy Reductions

Mary Caffrey

A profile of a program that calls for residents in a rural area to become full partners in managing their type 2 diabetes, and in the process bring changes to their community.

September 28th 2018

Welldoc Touts What Clinical Outcomes, Engagement Mean to Employers

Mary Caffrey

Employers who have been disappointed in the past with wellness programs want to see evidence of patient engagement and how this translates into savings.

September 28th 2018

Is It Time to Remodel Diabetes Self-Management Education and Support?

Hope S. Warshaw, MMSc, RD, CDE, BC-ADM

A former president of the American Association of Diabetes Educators addresses the need to remodel diabetes self-management education and support, to create a reimbursement system that better meets the needs of today's providers and patients.

September 28th 2018

In the Era of Payment Reform, Diabetes Educators Can Lead the Way Toward Value-Based Care

Robert Gabbay, MD, PhD, FACP

This article is based on a keynote presentation at the 2018 annual conference of the American Association of Diabetes Educators.

September 28th 2018

Dr Robert Gabbay: New Therapy Options Make It Easier to Manage Patients With Diabetes

There are a growing number of diabetes therapies, which has led to the need to individualize choices based on patient profile, said Robert A. Gabbay, MD, PhD, FACP, senior vice president and chief medical officer of Joslin Diabetes Center.

September 28th 2018

This Week in Managed Care: September 28, 2018

This week, the top managed care news included comments to several proposals from CMS; Medicare advocates say voters will be motivated by healthcare cost concerns during the midterm elections; research showed diabetes drug dapagliflozin, an SGLT2 inhibitor, reduces risks of major cardiovascular events.

September 24th 2018

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

Mary Caffrey

Full results from the cardiovascular outcomes trial for dapagliflozin (Farxiga) will be presented at the American Heart Association annual meeting in November.

September 21st 2018

US Women Have Higher Risk of Dying Prematurely, Report Says

Allison Inserro

In the United States, a woman age 30 to 70 years of age has a 1 in 8 chance of dying from a noncommunicable disease (NCDs), putting the nation on par with low and middle-income countries, and setting it apart with Iceland among high-income countries, according to a report published Thursday in The Lancet.

September 20th 2018

Gene Curbs Obesity by Reducing Inflammation, Aiding Healthy Gut Bacteria

Mary Caffrey

A series of experiments identified both "good" and "bad" gut bacteria, suggesting possible treatments for obesity.

September 19th 2018

A Multidisciplinary Approach to Managing Complexities in Cancer Care

As September marks National Ovarian Cancer Awareness Month, we sat down with ovarian cancer survivor Marion Roth and Vaagn Andikyan, MD, gynecologic oncologist, Western Connecticut Health Network, to discuss Marion's cancer journey and the importance of a multidisciplinary care team in treating complexities in cancer care.

September 14th 2018

Language Barriers and LDL-C/SBP Control Among Latinos With Diabetes

Alicia Fernandez, MD E. Margaret Warton, MPH Dean Schillinger, MD Howard H. Moffet, MPH Jenna Kruger, MPH Nancy Adler, PhD Andrew J. Karter, PhD

Among Latino patients with diabetes, ethnicity and language barriers were not associated with lipid and blood pressure control despite their associations with glycemic control in prior research. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.

September 1st 2018

Review Outlines Algorithm for Managing Diabetes With Increased Fracture Risk

Alison Rodriguez

Fragility fractures are a serious complication of type 1 and type 2 diabetes, but many clinicians who treat patients with diabetes are not aware of the increased risk of these fractures.

September 1st 2018

Podcast: This Week in Managed Care—Next Gen ACO Success and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

August 31st 2018

This Week in Managed Care: August 31, 2018

This week, the top managed care stories included encouraging results from the Next Generation Accountable Care Organization model; concerns that CMS' new billing rules will hurt the sickest patients; a study confirms the value of daily aspirin for patients with diabetes.

August 29th 2018

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds

Mary Caffrey

The analysis of patient records found no elevated risk of retinopathy among those using glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes.

August 27th 2018

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

Surabhi Dangi-Garimella, PhD

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

August 23rd 2018

Antihyperglycemic Medications for Cardiovascular Disease Risk Reduction

Jennifer D. Goldman, PharmD, RPh, CDE, BC-ADM, FCCP

August 23rd 2018

Economic Implications With Newer Agents to Reduce Cardiovascular Risk in Diabetes

Carrie McAdam-Marx, MSCI, PhD, RPh

August 23rd 2018

The Burden of Cardiovascular Disease in Patients with Diabetes

Brooke Hudspeth, PharmD, CDE

August 23rd 2018

From Diabetes Professional to Change Agent: The Shift That Population Health Requires

Mary Caffrey

A leader at the Institute for Healthcare Improvement offers a framework for diabetes educators to embrace a shift in thinking about healthcare delivery.

August 21st 2018

The Role of Technology in Preventing and Managing Diabetes

Given the high cost of treating diabetes and the large population with prediabetes, prevention has become a point of focus. We’re taking a look back to 2017, when The American Journal of Managed Care® convened a panel of experts to discuss diabetes prevention and the use of technology.

August 21st 2018

Dr Robert Gabbay Explains Controversy Over Recent A1C Guidelines

Robert A. Gabbay, MD, PhD, FACP, senior vice president and chief medical officer of Joslin Diabetes Center, explains why the Joslin Diabetes Center and the American Diabetes Association oppose the decision by the American College of Physicians to recommend a higher A1C target across the board.

August 20th 2018

Oral Semaglutide Offers Superior A1C Reduction, Weight Loss in PIONEER 5 Trial

Mary Caffrey

Patients with type 2 diabetes and moderate renal impairment who took oral semaglutide in a phase 3a trial reported a larger reduction in glycated hemoglobin and more weight loss than patients taking placebo.

August 19th 2018

Update on Diabetes Prevention Program Seeks Progress on Referrals, Reimbursement

Mary Caffrey

Three federal officials discussed the status of research, payer coverage, and referrals for the National Diabetes Prevention Program, as well as the rollout of the Medicare program for eligible seniors.

August 18th 2018

Finding the Golden Opportunity in Becoming a Diabetes e-Educator

Mary Caffrey

The rise of digital health alongside the transformation of reimbursement from fee-for-service to value-based care is allowing patients to fully participate in their own care, according to a leader with one of the top digital health companies in diabetes care.

August 17th 2018

Payment Reform Reveals Value of Diabetes Educators in Driving Down Healthcare Costs, Joslin's Gabbay Says

Mary Caffrey

Robert A. Gabbay, MD, PhD, FACP, chief medical officer and senior vice president at Joslin Diabetes Center, said health systems need people with the skill sets that diabetes educators possess to make the transition to a reimbursement system based on quality, prevention, and eliminating costs.

...

24 25 26 27 28 29 30 31 32

...

99 >

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

Do Not Sell My Information

Terms & Conditions